Discover
PTGX
Protagonist Therapeutics, Inc.
125.17
2 x 90.28
2 x 157.31
bid
ask
+
2.59
2.11%
2 @ 04:32 AM
124.67 -0.50 (0.40%)
| Ytd | 43.31% | |
| 1y | 146.93% |
122.50
day range
126.04
49.38
52 week range
126.59
| Open | 122.96 | Prev Close | 122.58 | Low | 122.50 | High | 126.04 | Mkt Cap | 8.05B |
| Vol | 490.15K | Avg Vol | 691.19K | EPS | -1.81 | P/E | N/A | Forward P/E | -179.04 |
| Beta | 1.83 | Short Ratio | 13.55 | Inst. Own | 125.29% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-05 | 50-d Avg | 105.19 | 200-d Avg | 90.00 | 1yr Est | 118.69 |
| Income Statement | |||
| Total Revenue | 56.37M | ||
| Revenues (USD) | 56.37M | ||
| Gross Profit | 56.37M | ||
| Operating Expenses | 60.02M | ||
| Research and Development Expense | 46.74M | ||
| Selling, General and Administrative Expense | 13.28M | ||
| Operating Income | -3.65M | ||
| Income Tax Expense | -1.50M | ||
| Net Income | 3.78M | ||
| Net Income Common Stock | 3.78M | ||
| Net Income Common Stock (USD) | 3.78M | ||
| Consolidated Income | 3.78M | ||
| Earnings per Basic Share | 0.06 | ||
| Earnings per Basic Share (USD) | 0.06 | ||
| Earnings per Diluted Share | 0.05 | ||
| Earning Before Interest & Taxes (EBIT) | 2.28M | ||
| Earning Before Interest & Taxes (USD) | 2.28M | ||
| Weighted Average Shares | 65.09M | ||
| Weighted Average Shares Diluted | 70.49M | ||
| Balance Sheet | |||
| Cash and Equivalents | 193.71M | ||
| Cash and Equivalents (USD) | 193.71M | ||
| Investments | 426.62M | ||
| Investments Current | 354.07M | ||
| Investments Non-Current | 72.55M | ||
| Trade and Non-Trade Receivables | 53.66M | ||
| Current Assets | 613.46M | ||
| Property, Plant & Equipment Net | 11.17M | ||
| Total Assets | 697.46M | ||
| Debt Current | 2.34M | ||
| Total Debt | 9.78M | ||
| Current Liabilities | 34.55M | ||
| Debt Non-Current | 7.44M | ||
| Total Liabilities | 41.99M | ||
| Accumulated Retained Earnings (Deficit) | -466.89M | ||
| Accumulated Other Comprehensive Income | -269.00K | ||
| Shareholders Equity | 655.47M | ||
| Shareholders Equity (USD) | 655.47M | ||
| Assets Non-Current | 84.00M | ||
| Total Debt (USD) | 9.78M | ||
| Deferred Revenue | 6.28M | ||
| Liabilities Non-Current | 7.44M | ||
| Trade and Non-Trade Payables | 8.44M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 846.00K | ||
| Net Cash Flow from Financing | 23.37M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 65.32M | ||
| Capital Expenditure | -215.00K | ||
| Net Cash Flow from Investing | 90.89M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 91.11M | ||
| Net Cash Flow from Operations | -48.94M | ||
| Share Based Compensation | 14.52M | ||